4D Molecular Therapeutics FDMT
NASDAQ FDMT
$12.62 -0.48 (-3.66%)
At close: Oct 21, 2026 · 4:00 PM EDT

4D Molecular Therapeutics (FDMT) Invested Capital (2025 - 2026)

Updated

4D Molecular Therapeutics' Invested Capital came in at $427.25 million for Q2 2026.

Analysis

4D Molecular Therapeutics (FDMT) Invested Capital (2025 - 2026) Analysis & Trends

For FY2025, 4D Molecular Therapeutics' Invested Capital was $505.66 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 134.01 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 64.89 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 51.53 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 82.72 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 38.08 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 148.69 Bn
10 4D Molecular Therapeutics 891.75 Mn -568.19 Mn - 427.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 427.25 Mn
Dec 31, 2025 505.66 Mn
API Access

4D Molecular Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=FDMT&period=max&api_key=YOUR_API_KEY